Abbott India Limited (BSE: 500488)
Health Care · Pharmaceuticals · IN
Rs25,999.85
-3.10% today · -13.8% 1Y
Abbott India Limited (BSE: 500488) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $5.71B.
Over the last twelve months the share price has lost 13.8%, trading between 25.14K and 30.60K.
Tweenvest scores Abbott India Limited across four factors: quality 90/100, value 74/100, growth 71/100, dividend 81/100. Its strongest factor is quality.
500488 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.71B
- Revenue (TTM)
- $740.80M
- P/E
- 34.22
- EPS
- 759.88
- Dividend yield
- 2.02%
- Beta (5Y)
- 0.06
- 52-week high
- Rs30,598.00
- 52-week low
- Rs25,140.50
- Avg volume (3M)
- —
- Shares outstanding
- 21.25M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Alkem Laboratories LimitedNSEI: ALKEM | $6.52B | Rs5,279.00 | +1.13% |
| Belite Bio, IncNasdaqCM: BLTE | $6.22B | $159.28 | +3.10% |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999 | $6.17B | CN¥24.82 | +1.39% |
| Ligand Pharmaceuticals IncorporatedNasdaqGM: LGND | $6.02B | $305.19 | +1.12% |
| Shanghai Allist Pharmaceuticals Co., Ltd.SHSE: 688578 | $5.54B | CN¥82.50 | -26.06% |
| Veradermics, IncorporatedNYSE: MANE | $5.47B | $125.45 | -4.17% |
| Gland Pharma LimitedNSEI: GLAND | $5.22B | Rs3,061.80 | +6.52% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.12B | CN¥30.93 | +0.88% |
Figures last refreshed Oct 11, 2026.